Hyperparathyroidism risk factors: Difference between revisions
No edit summary |
m (Bot: Removing from Primary care) |
||
| (16 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
{{Hyperparathyroidism}} | {{Hyperparathyroidism}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Anmol}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of primary hyperparathyroidism include [[postmenopausal]] women, age group 50-60 year, family history of hyperparathyroidism, and history of familial syndromes. Common risk factors in the development of secondary hyperparathyroidism in [[chronic renal failure]] include [[Hyperphosphatemia|high serum phosphorus]] expression levels, low serum [[creatinine]] expression levels, [[Hypocalcemia|low serum calcium]] expression levels, female gender, and [[hypertension]]. Common risk factors in the development of tertiary hyperparathyroidism post [[renal transplantation]] include elderly individuals and longer duration of [[dialysis]]. | |||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of primary hyperparathyroidism include [[postmenopausal]] women, age group 50-60 year, family history of hyperparathyroidism, and history of familial syndromes. | |||
Common risk factors in the development of secondary hyperparathyroidism in [[chronic renal failure]] include [[Hyperphosphatemia|high serum phosphorus]] expression levels, low serum [[creatinine]] expression levels, [[Hypocalcemia|low serum calcium]] expression levels, female gender, and [[hypertension]]. | |||
Common risk factors in the development of tertiary hyperparathyroidism post [[renal transplantation]] include elderly individuals and longer duration of [[dialysis]]. | |||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
Common risk factors in the development of primary hyperparathyroidism include: | |||
*[[Postmenopausal]] women | |||
**[ | *Age group 50-60 years | ||
**[risk | *Family history of hyperparathyroidism | ||
**[ | *History of familial syndromes such as [[multiple endocrine neoplasia type 1]], [[Multiple endocrine neoplasia type 2A|type 2A]] or [[Multiple endocrine neoplasia type 4|type 4]]; [[familial hypocalciuric hypercalcemia]], hyperparathyroid-jaw tumor syndrome | ||
Common risk factors in the development of secondary hyperparathyroidism in chronic renal failure include:<ref name="pmid27446345">{{cite journal |vauthors=Wei Y, Lin J, Yang F, Li X, Hou Y, Lu R, Shi X, Liu Z, Du Y |title=Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease |journal=Exp Ther Med |volume=12 |issue=2 |pages=1206–1212 |year=2016 |pmid=27446345 |pmc=4950648 |doi=10.3892/etm.2016.3438 |url=}}</ref> | |||
*[[Hyperphosphatemia|High serum phosphorus]] expression levels | |||
*Low serum [[creatinine]] expression levels | |||
*[[Hypocalcemia|Low serum calcium]] expression levels | |||
*Female gender | |||
*[[Hypertension]] | |||
Common risk factors in the development of tertiary hyperparathyroidism post [[Kidney transplantation|renal transplantation]] include:<ref name="pmid19587496">{{cite journal |vauthors=Hamidian Jahromi A, Roozbeh J, Raiss-Jalali GA, Dabaghmanesh A, Jalaeian H, Bahador A, Nikeghbalian S, Salehipour M, Salahi H, Malek-Hosseini A |title=Risk factors of post renal transplant hyperparathyroidism |journal=Saudi J Kidney Dis Transpl |volume=20 |issue=4 |pages=573–6 |year=2009 |pmid=19587496 |doi= |url=http://www.sjkdt.org/article.asp?issn=1319-2442;year=2009;volume=20;issue=4;spage=573;epage=576;aulast=Jahromi}}</ref> | |||
*Elderly individuals | |||
*Longer duration of [[dialysis]] | |||
===Less Common Risk Factors=== | ===Less Common Risk Factors=== | ||
*Less common risk factors in the development of [ | Less common risk factors in the development of primary hyperparathyroidism include: | ||
**[ | *history of current or past [[lithium]] use<ref>{{cite journal |last1=Szalat |first1=Auryan |last2=Mazeh |first2=Haggi |last3=Freund |first3=Herbert R |date=2009 |title=Lithium-associated hyperparathyroidism: report of four cases and review of the literature |url=http://www.eje-online.org/content/160/2/317.full.pdf |journal=European Journal of Endocrinology |volume=160 |issue= |pages=317–323 |doi= |access-date= }}</ref> | ||
* | *Exposure to head and neck [[radiation]] | ||
* | Less common risk factors in the development of secondary hyperparathyroidism in [[chronic renal failure]] include:<ref name="pmid27446345">{{cite journal |vauthors=Wei Y, Lin J, Yang F, Li X, Hou Y, Lu R, Shi X, Liu Z, Du Y |title=Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease |journal=Exp Ther Med |volume=12 |issue=2 |pages=1206–1212 |year=2016 |pmid=27446345 |pmc=4950648 |doi=10.3892/etm.2016.3438 |url=}}</ref> | ||
*[[Acidosis]] | |||
*[[Anemia]] | |||
*[[Hyperlipidemia]] | |||
*Micro-[[inflammation]] ([[C reactive protein]]) | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
| Line 33: | Line 42: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
| |||
[[Category:Disease]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Parathyroid disorders]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 22:16, 29 July 2020
|
Hyperparathyroidism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hyperparathyroidism risk factors On the Web |
|
American Roentgen Ray Society Images of Hyperparathyroidism risk factors |
|
Risk calculators and risk factors for Hyperparathyroidism risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Common risk factors in the development of primary hyperparathyroidism include postmenopausal women, age group 50-60 year, family history of hyperparathyroidism, and history of familial syndromes. Common risk factors in the development of secondary hyperparathyroidism in chronic renal failure include high serum phosphorus expression levels, low serum creatinine expression levels, low serum calcium expression levels, female gender, and hypertension. Common risk factors in the development of tertiary hyperparathyroidism post renal transplantation include elderly individuals and longer duration of dialysis.
Risk Factors
Common risk factors in the development of primary hyperparathyroidism include postmenopausal women, age group 50-60 year, family history of hyperparathyroidism, and history of familial syndromes.
Common risk factors in the development of secondary hyperparathyroidism in chronic renal failure include high serum phosphorus expression levels, low serum creatinine expression levels, low serum calcium expression levels, female gender, and hypertension.
Common risk factors in the development of tertiary hyperparathyroidism post renal transplantation include elderly individuals and longer duration of dialysis.
Common Risk Factors
Common risk factors in the development of primary hyperparathyroidism include:
- Postmenopausal women
- Age group 50-60 years
- Family history of hyperparathyroidism
- History of familial syndromes such as multiple endocrine neoplasia type 1, type 2A or type 4; familial hypocalciuric hypercalcemia, hyperparathyroid-jaw tumor syndrome
Common risk factors in the development of secondary hyperparathyroidism in chronic renal failure include:[1]
- High serum phosphorus expression levels
- Low serum creatinine expression levels
- Low serum calcium expression levels
- Female gender
- Hypertension
Common risk factors in the development of tertiary hyperparathyroidism post renal transplantation include:[2]
- Elderly individuals
- Longer duration of dialysis
Less Common Risk Factors
Less common risk factors in the development of primary hyperparathyroidism include:
Less common risk factors in the development of secondary hyperparathyroidism in chronic renal failure include:[1]
References
- ↑ 1.0 1.1 Wei Y, Lin J, Yang F, Li X, Hou Y, Lu R, Shi X, Liu Z, Du Y (2016). "Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease". Exp Ther Med. 12 (2): 1206–1212. doi:10.3892/etm.2016.3438. PMC 4950648. PMID 27446345.
- ↑ Hamidian Jahromi A, Roozbeh J, Raiss-Jalali GA, Dabaghmanesh A, Jalaeian H, Bahador A, Nikeghbalian S, Salehipour M, Salahi H, Malek-Hosseini A (2009). "Risk factors of post renal transplant hyperparathyroidism". Saudi J Kidney Dis Transpl. 20 (4): 573–6. PMID 19587496.
- ↑ Szalat, Auryan; Mazeh, Haggi; Freund, Herbert R (2009). "Lithium-associated hyperparathyroidism: report of four cases and review of the literature" (PDF). European Journal of Endocrinology. 160: 317–323.